According to the Report, the Size of the African Horse Sickness Treatment Market in the Asia Pacific is valued at USD XX billion in 2022 and is expected to reach USD xx billion by 2027, to grow at a CAGR of xx.x% during the forecast period 2022 to 2027.
Asia Pacific African horse sickness treatment (AHS) market will be advantageous for various preventive vaccines in research and development efforts, contributing to market growth. In addition, the existence of standard operating procedures and guidelines for the African horse sickness condition is a key driver driving the African horse sickness treatment market.
The growing number of non-government and government efforts to raise awareness about the need for immunization in preventing life-threatening illnesses in animals is expected to enhance the Asia Pacific African Horse Sickness Treatment market. Horses, which are the most susceptible to the disease, can have a mortality rate of up to 95%, whereas males have a lower risk, and donkeys are exempt from African Horse Sickness Disease. Therefore, a good vaccination program and a healthy dietary program, and regular deworming are preventive techniques for African horse sickness treatment.
Prevention programs are a practical and cost-effective strategy to avoid common infectious diseases in horses. There is currently no specific therapy for the treatment of African horse disease, and it is recommended that horses be kept away from the disease. Treatment that is supportive Treatment for African horse sickness is indicated. For the number of vaccinations in development, the African horse sickness treatment (AHS) market is a rising market. Furthermore, the multivalent, modified-live vaccine does not guarantee that it will protect horses from African horse sickness; it reduces the risk of infection.
The modified-live, multivalent vaccine does not guarantee that the horses will be completely protected against African horse sickness, only that their risks of contracting the disease will be lowered, restricting the growth of the Asia Pacific African horse sickness treatment market.
This research report on the Asia Pacific African Horse Sickness Treatment Market has been segmented and sub-segmented into the following categories.
By Clinical Form:
By Diagnosis:
By Country:
Geographically, the Asia Pacific African Horse Sickness Treatment Market is increasing significantly because of the emerging regional competitors in this region. Therefore, the market will grow across all areas during the period.
The India African Horse Sickness Treatment Market contributes to the market growth because of the developing healthcare infrastructure and more awareness about horse vaccination.
For example, in Asia, an epidemic of African horse sickness, sometimes known as the African Plague, killed about 550 horses and devastated approximately 12 provinces.
The China African Horse Sickness Treatment Market growth is rising rapidly and has seen the rise of several companies, and will see a significant expansion during the forecast period.
The Japan African Horse Sickness Treatment Market is predicted to rise due to the increased awareness about horse vaccination, developing healthcare infrastructure, and rapid expansion of healthcare infrastructure across Asian countries. These are the factors that would drive the growth of the African horse illness treatment market in Asia-Pacific. As a result, the need for African horse sickness medication would increase across the continent.
KEY MARKET PLAYERS
Top Companies dominating the Asia Pacific African Horse Sickness Treatment Market Profiled in the Report are Onderstepoort Biological Products SOC Ltd, Veterinary Serum, Vaccine Research Institute.,
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Clinical forms
5.1.1 Introduction
5.1.2 Dikkop or Cardiac form
5.1.3 Dunkop or Pulmonary form
5.1.4 Horse sickness fever
5.1.5 Mixed form
5.1.6 Y-o-Y Growth Analysis, By Clinical forms
5.1.7 Market Attractiveness Analysis, By Clinical forms
5.1.8 Market Share Analysis, By Clinical forms
5.2 Diagnosis
5.2.1 Introduction
5.2.2 Prevention treatment
5.2.2.1 Vaccines
5.2.3 Diagnostic tests
5.2.3.1 Laboratory tests for viral antigens
5.2.3.2 Serological tests
5.2.4 Y-o-Y Growth Analysis, By Diagnosis
5.2.5 Market Attractiveness Analysis, By Diagnosis
5.2.6 Market Share Analysis, By Diagnosis
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Clinical forms
6.1.3.3 By Diagnosis
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Clinical forms
6.1.4.3 By Diagnosis
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Clinical forms
6.1.5.3 By Diagnosis
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
6.7 Rest of Asia Pacific
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Veterinary Serum and Vaccine Research Institute
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Onderstepoort Biological Products SOC
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.